Music Therapy to Prevent Hospital-acquired Delirium in Parkinson's Disease and Dementia With Lewy Bodies
Launched by UNIVERSITY OF MASSACHUSETTS, WORCESTER · Sep 26, 2023
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Participants will be screened within 24 hours of inpatient admission to UMass Memorial Medical Center, University Campus (Worcester, MA).
Participants will be randomized equally to one of three groups: 1) Music therapy (MT), 2) Active Control, 3) Standard of Care.
Participants will receive the assigned intervention within 48 hours of admission, and this will continue up to the day of discharge. If a participant remains hospitalized for more than 15 days, the assigned intervention will stop at Day 15.
The study groups are described below:
MT arm:
Participants will undergo one-on-one mus...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Admitted as inpatient to UMass Memorial Medical Center University Campus
- • Diagnosis of PD or DLB (ICD-10 G20 and G31.83 respectively) on active problem list or past medical history OR carbidopa/levodopa on active medication list or ordered in admission orders.
- Exclusion Criteria:
- • Severe hearing loss (unable to perceive sound \< 71dB)
- • Professed dislike or lack of reward with experiencing of all types of music (Barcelona Music Reward Questionnaire total score \<40)
- • History of musicogenic seizures
- • Delirium present at initial assessment, as determined by a positive Confusion Assessment Method (CAM)
- • Admitted to observation status or to Clinical Decision Unit (as these patients would not be expected to remain inpatient long enough to undergo the MT intervention)
- • Patients who are currently prisoners will not be included
- • Patients admitted and discharged within 24 hours.
- • Patients in the intensive care unit receiving continuous intravenous sedative medication (as they would not be expected to be able to meaningfully participate in the study activities).
About University Of Massachusetts, Worcester
The University of Massachusetts Worcester is a leading academic institution dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the university integrates cutting-edge scientific inquiry with a commitment to improving patient outcomes. Its collaborative approach engages a diverse range of experts, fostering interdisciplinary research that addresses pressing health challenges. With a focus on ethical standards and regulatory compliance, the University of Massachusetts Worcester plays a pivotal role in translating scientific discoveries into practical applications that enhance medical practice and patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Worcester, Massachusetts, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported